Patent details

Basic Information

Publication number:

EP2243475

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100753235

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Combination of memantine and donepezil for treatment of CNS disorders

French Title of Invention:

Combinaison de mémantine et donépézil pour le traitement de conditions relatives au SNC

German Title of Invention:

Kombination von Memantin und Donepezil zur Behandlung von Erkrankungen des ZNS

SPC Number:

Dates

Filing date:

06/04/2006

Grant date:

13/01/2016

EP Publication Date:

13/01/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/10/2010

EP B1 Publication Date:

13/01/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/04/2016

Expiration date:

06/04/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/04/2006

 

 

Name:

Adamas Pharmaceuticals Inc.

Address:

1900 Powell Street, Suite 750, Emeryville, CA 94608, United States (US)

Inventor

1

Name:

Went Gregory T.

Address:

United States (US)

2

Name:

Fultz Timothy J.

Address:

United States (US)

Priority

1

Priority Number:

669290 P

Priority Date:

06/04/2005

Priority Country:

United States (US)

2

Priority Number:

285905

Priority Date:

22/11/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/13;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages